Nested Therapeutics

Cambridge, United States

Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.

$90.0M raised

Oct 2022

Series A

Biotechnology Health Care Pharmaceutical

Top Investors

Foresite Capital Avidity Partners Versant Ventures S32 Goldman Sachs Asset Management

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nested Therapeutics

How much funding has Nested Therapeutics raised?

Nested Therapeutics has raised $90.0M in total funding. The most recent round was Series A. The last funding was announced in October 2022.

Who are Nested Therapeutics's investors?

Nested Therapeutics's investors include Foresite Capital, Avidity Partners, Versant Ventures, S32, Goldman Sachs Asset Management.

Where is Nested Therapeutics headquartered?

Nested Therapeutics is headquartered in Cambridge, United States.

What does Nested Therapeutics do?

Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.

What stage is Nested Therapeutics at?

Nested Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 6, 2022.

MLA

"Nested Therapeutics — Funding & Investors." VCBacked, October 6, 2022, https://www.vcbacked.co/company/nested-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Nested Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/nested-therapeutics

Wikipedia (cite web)

{{cite web |title=Nested Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nested-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 6, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K